AUREOGEN BIOSCIENCES, INC.

Basic Information

6475 Technology Avenue, Ste C
KALAMAZOO, MI, 49009-

Company Profile

n/a

Additional Details

Field Value
DUNS: 139133339
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Novel Antifungals by Engineering the AbA NRPS gene

    Amount: $481,481.00

    DESCRIPTION (provided by applicant): The continuing increase in the number of surgery, transplantation, cancer and other immunocompromized patients, that need treatment for fungal infections, together ...

    SBIR Phase II 2011 Department of Health and Human Services
  2. Generation of novel HCV drugs through engineereing of the cssA gene

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): HCV infections are a prevalent and growing health problem. It is estimated that as many as 2% of the US population, and 2.5% of the population world-wide, are infe ...

    SBIR Phase I 2008 Department of Health and Human Services
  3. Generation of novel drugs against drug resistant bacteria through engineering of

    Amount: $286,746.00

    DESCRIPTION (provided by applicant): The number of patients treated for antibiotics-resistant bacterial infections has increased drastically in recent years. What started as a problem primarily associ ...

    SBIR Phase I 2008 Department of Health and Human Services
  4. A Bacitracin derivative for systemic use

    Amount: $381,116.00

    DESCRIPTION (provided by applicant): The number of patients treated for antibiotics-resistant infections has increased drastically in recent years. What started as a problem primarily associated with ...

    SBIR Phase I 2007 Department of Health and Human Services
  5. Novel Antifungals by Engineering the AbA NRPS gene

    Amount: $1,978,700.00

    DESCRIPTION (provided by applicant): There is an immediate need for novel drugs for the treatment of fungal infections, (antibiotics resistant) bacterial infections, and cancer. Cyclic peptides consti ...

    SBIR Phase II 2006 Department of Health and Human Services
  6. Novel Antifungals by Engineering the AbA NRPS gene

    Amount: $162,982.00

    DESCRIPTION (provided by applicant): There is an immediate need for efficient, novel antifungal drugs. The fungus Aureobasidium pullulans produces a cyclic peptide know as Aureobasidin A (AbA) which ...

    SBIR Phase I 2004 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government